{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T18:18:32Z","timestamp":1792347512216,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bbr.2020.112769","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T12:26:10Z","timestamp":1591878370000},"page":"112769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex"],"prefix":"10.1016","volume":"393","author":[{"given":"Marta","family":"Hereta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Bia\u0142o\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"W\u0105sik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Lorenc-Koci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Rog\u00f3\u017c","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2020.112769_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","article-title":"The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor","volume":"441","author":"Jordan","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112769_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1742-1241.2003.tb11397.x","article-title":"Aripiprazole: a review its pharmacology and clinical use","volume":"57","author":"Taylor","year":"2003","journal-title":"Int. J. Clin. Pract. Suppl."},{"key":"10.1016\/j.bbr.2020.112769_bib0015","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2020.112769_bib0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-2918(04)90066-5","article-title":"Aripiprazole, a comprehensive review of its pharmacology, clinical efficacy, and tolerability","volume":"26","author":"DeLeon","year":"2004","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbr.2020.112769_bib0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2003.09.003","article-title":"Animal behavior models of the mechanisms underlying antipsychotic atypicality","volume":"27","author":"Geyer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112769_bib0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","article-title":"Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism","volume":"128","author":"Neill","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbr.2020.112769_bib0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00213-006-0658-y","article-title":"The atypical antipsychotic, aripiprazole, blocks phencyclidine \u2013induced disruption of prepulse inhibition in mice","volume":"191","author":"Fejgin","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.112769_bib0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00213-008-1240-6","article-title":"Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors","volume":"202","author":"Nagai","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.112769_bib0045","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1471-4159.1990.tb01230.x","article-title":"Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study","volume":"54","author":"Moghaddam","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2020.112769_bib0050","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0022-3565(24)38019-X","article-title":"Effect of antipsychotic drugs on extracellular dopamine levels in the rat medial prefrontal cortex and nucleus accumbens","volume":"288","author":"Kuraki","year":"1999","journal-title":"J. Pharmacol. Exper. Ther."},{"key":"10.1016\/j.bbr.2020.112769_bib0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0006-8993(02)02544-1","article-title":"5HT(1A) and 5-HT (2A) receptors minimalny contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex","volume":"939","author":"Ichikawa","year":"2002","journal-title":"Brein Res."},{"key":"10.1016\/j.bbr.2020.112769_bib0060","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0893-133X(01)00312-8","article-title":"Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum","volume":"26","author":"Ichikawa","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2020.112769_bib0065","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","article-title":"5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release","volume":"76","author":"Ichikawa","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2020.112769_bib0070","first-page":"144","article-title":"Dopamine D2 receptor occupancy and the action of clozapine: does it make a difference to add a neuroleptics?","volume":"46","author":"Meltzer","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112769_bib0075","first-page":"75","article-title":"Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain, Eur","volume":"493","author":"Li","year":"2004","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112769_bib0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2004.09.007","article-title":"Identification of separable cognitive factors in schizophrenia","volume":"72","author":"Nuechterlein","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbr.2020.112769_bib0085","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/1531-8249(200010)48:4<556::AID-ANA2>3.0.CO;2-2","article-title":"Neurobiology of schizophrenia","volume":"48","author":"Pearlson","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbr.2020.112769_bib0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2020.112769_bib0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2009.11.008","article-title":"The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial","volume":"116","author":"Abbasi","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbr.2020.112769_bib0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pnpbp.2010.11.006","article-title":"Mirtazapine augmentation enhances cognitive and reduced negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial","volume":"35","author":"Cho","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112769_bib0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-002-1364-z","article-title":"Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities","volume":"167","author":"S\u00e1nchez","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2020.112769_bib0110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00023210-200923050-00006","article-title":"Mirtazapine: a review of its use in major depression and other psychiatric disorders","volume":"23","author":"Croom","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbr.2020.112769_bib0115","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.pharep.2019.04.007","article-title":"Co-treatment with antidepressants and aripiprazole reversed the MK-801-induced some negative symptoms of schizophrenia in rats","volume":"71","author":"Hereta","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbr.2020.112769_bib0120","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.2174\/1381612819666131216114240","article-title":"The novel object recognition test in rodents in relative to cognitive impairment in schizophrenia","volume":"20","author":"Rajagopal","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbr.2020.112769_bib0125","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.neuropharm.2005.05.013","article-title":"Effect of novel antipsychotics with mixed D2 antagonist\/5-HT1A agonist properties on PCP-induced social interaction deficits in the rat","volume":"49","author":"Bruins Slot","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2020.112769_bib0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/syn.890190207","article-title":"Cellular colocalization of dopamine D1 and D2 receptors in the medial prefrontal cortex","volume":"19","author":"Vincent","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2020.112769_bib0135","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1523\/JNEUROSCI.2999-05.2005","article-title":"Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action","volume":"25","author":"Diaz-Mataix","year":"2005","journal-title":"J. Neurosc."},{"key":"10.1016\/j.bbr.2020.112769_bib0140","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.pharep.2015.04.006","article-title":"The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats","volume":"67","author":"Kami\u0144ska","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbr.2020.112769_bib0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/syn.21510","article-title":"Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence","volume":"66","author":"Marcus","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2020.112769_bib0150","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S1734-1140(13)71499-3","article-title":"Effect of combined treatment with mirtazapine and risperidone on the MK-801-induced changes in the object recognition test in mice","volume":"65","author":"Rog\u00f3\u017c","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbr.2020.112769_bib0155","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.pharep.2018.02.022","article-title":"Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice","volume":"70","author":"Rog\u00f3\u017c","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbr.2020.112769_bib0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2003.10.025","article-title":"In vivo effects of aripiprazole on cortical and striatal dopaminergic aad serotonergic function","volume":"483","author":"Jordan","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112769_bib0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.105.087163","article-title":"Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain","volume":"315","author":"Assie","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2020.112769_bib0170","first-page":"785","article-title":"Behavioral and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brain","volume":"34","author":"Semba","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2020.112769_bib0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2005.06.035","article-title":"Aripiprazole increases dopamine but not naradrenaline and serotonin levels in the mouse prefrontal cortex","volume":"387","author":"Zocchi","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2020.112769_bib0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(96)00150-1","article-title":"Ipsapirone enhances the dopamine outflow via 5-HT1A-receptors in the rat prefrontal cortex","volume":"30","author":"W\u0119dzony","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112769_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/S0028-3908(01)00087-9","article-title":"Noradrenergic modulation of serotonin release in rat dorsal and median raphe nuclei via \u03b11and \u03b12 adrenoceptors","volume":"41","author":"Hopwood","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2020.112769_bib0190","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00213-007-0698-y","article-title":"In vivo action of aripiprazole on serotonergic and dopaminergic systems in rodent brain","volume":"191","author":"Bartolozzi","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.112769_bib0195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0028-3908(80)90187-2","article-title":"Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoreceptor antagonists","volume":"19","author":"Baraban","year":"1980","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2020.112769_bib0200","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.pharep.2014.06.009","article-title":"The effect of risperidone on the mirtazapine-induced changes in extracellular monoamines in the rat frontal cortex","volume":"66","author":"Kami\u0144ska","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbr.2020.112769_bib0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainresbull.2004.02.007","article-title":"Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"63","author":"Nakayama","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbr.2020.112769_bib0210","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0306-4522(97)00565-4","article-title":"Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of free-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor mediated control release","volume":"84","author":"Gobert","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2020.112769_bib0215","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0306-4522(99)00211-0","volume":"93","author":"Gobert","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2020.112769_bib0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000104877","article-title":"Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the in the mouse forced swim test","volume":"80","author":"Dhir","year":"2007","journal-title":"Pharmacology"},{"key":"10.1016\/j.bbr.2020.112769_bib0225","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1471-4159.1993.tb02148.x","article-title":"Endogenous noradrenaline activates alpha 2-adrenoreceptors on serotonergic nerve endings in human and rat neocortex","volume":"61","author":"Feuerstein","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2020.112769_bib0230","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/BF00167444","article-title":"In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus","volume":"347","author":"Mongeau","year":"1993","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112769_bib0235","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0014-2999(84)90618-6","article-title":"Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons","volume":"105","author":"Freedman","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112769_bib0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(99)01339-6","article-title":"Histamine regulates food intake through modulating noradrenaline release in the para-ventricular nucleus","volume":"828","author":"Kurose","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2020.112769_bib0245","first-page":"1135","article-title":"Classics in chemical neuroscience: aripiprazole, ACS chem","volume":"8","author":"Casey","year":"2017","journal-title":"Neurosci."},{"issue":"Suppl","key":"10.1016\/j.bbr.2020.112769_bib0250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004714-199704001-00004","article-title":"The clinical relevance of preclinical data: mirtazapine, a model compound","volume":"17","author":"Delbressine","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2020.112769_bib0255","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1586\/14737175.1.2.171","article-title":"Newer antipsychotics: comparative review of drug interactions","volume":"1","author":"Spina","year":"2001","journal-title":"Exp. Rev. Neurotherapeutics"},{"key":"10.1016\/j.bbr.2020.112769_bib0260","doi-asserted-by":"crossref","DOI":"10.1016\/S1043-6618(03)00178-6","article-title":"Lack of pharmacokinetic interaction between mirtazapine and the newer antipsychotic clozapine, risperidone and olanzapine in patients with chronic schizophrenia","volume":"48","author":"Zoccali","year":"2003","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbr.2020.112769_bib0265","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/0269881108096522","article-title":"The pharmacokinetics of standard of antidepressants with aripiprazole as adjuctive therapy: studies in healthy subjects and patients with major depressive disordies","volume":"24","author":"Boulton","year":"2010","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.bbr.2020.112769_bib0270","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12202","article-title":"Symptomatic and functional outcomes and early prediction of response to escitalopram monotherapy and sequential adjuctive aripiprazole therapy in patients with major depressive disorder: a CAN-BINO-1-Report","volume":"80","author":"Kennedy","year":"2019","journal-title":"J. Clin. Psychiatry"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643282030468X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643282030468X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:19:58Z","timestamp":1759065598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016643282030468X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":54,"alternative-id":["S016643282030468X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2020.112769","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2020.112769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112769"}}